AKT1 and ovarian carcinoma: In ovarian cancer, ANO1 knockdown reduces PI3K/Akt phosphorylation, and the use of specific inhibitors can suppress ANO1-mediated ovarian cancer cell growth by targeting PI3K/Akt signaling (168).